 |
Previous Article | Next Article 
The Journal of Neuroscience, November 15, 2002, 22(22):9776-9784
Rab11a and Myosin Vb Regulate Recycling of the M4
Muscarinic Acetylcholine Receptor
Laura A.
Volpicelli1,
James J.
Lah1,
Guofu
Fang1,
James R.
Goldenring2, and
Allan I.
Levey1
1 Center for Neurodegenerative Disease and Department
of Neurology, Emory University School of Medicine, Atlanta, Georgia
30322, and 2 Department of Surgery, Vanderbilt University
School of Medicine, Nashville, Tennessee 37232
 |
ABSTRACT |
Agonist-induced internalization followed by subsequent return to
the cell surface regulates G-protein-coupled receptor (GPCR) activity.
Because the cellular responsiveness to ligand depends on the balance
between receptor degradation and recycling, it is crucial to identify
the molecules involved in GPCR recovery to the cell surface. In this
study, we identify mechanisms involved in the recycling of the
M4 subtype of muscarinic acetylcholine receptor.
M4 is highly expressed in the CNS, plays a role in
locomotor activity, and is a novel therapeutic target for neurologic
and psychiatric disorders. Previous studies show that, after
cholinergic stimulation, M4 internalizes from the cell
surface to endosomes in cell culture and the rat brain. Here, we show
that, after activation, M4 traffics to transferrin
receptor- and Rab11a-positive perinuclear endosomes. Expression of the
constitutively GDP-bound, inactive mutant Rab11aS25N inhibits
M4 trafficking to recycling endosomes. Expression of the
C-terminal tail of myosin Vb, a Rab11a effector, enhances
M4 accumulation in perinuclear endosomes. Both Rab11aS25N and the myosin Vb tail impair M4 recycling. The results
demonstrate that GPCR recycling is mediated through a discrete pathway
using both Rab11a and myosin Vb.
Key words:
PC12 cells; muscarinic acetylcholine receptors; G-protein-coupled receptor; M4; recycling; endosomes; Rab11a; myosin Vb; unconventional myosins; transferrin receptor; endocytosis; internalization
 |
INTRODUCTION |
Regulated intracellular trafficking
after stimulation controls activity and cell surface expression of
neurotransmitter receptors, including G-protein-coupled receptors
(GPCRs) and ion channels (Koenig and Edwardson, 1997 ; Lefkowitz, 1998 ;
Carroll et al., 2001 ; Roche et al., 2001 ; St. John and Gordon, 2001 ).
Agonist-induced GPCR internalization has been demonstrated in cell
culture and in the rat and human brain (Bloch et al., 1999 ; Muriel et
al., 1999 ). The balance between GPCR internalization and recycling to
the cell surface or degradation dictates the neuronal responsiveness to
ligand. Furthermore, GPCR trafficking plays a role in the physiological tolerance to drugs (Whistler et al., 1999 ; Finn and Whistler, 2001 ; He
et al., 2002 ). Because most treatments of CNS disorders include
long-term administration of agonists that target GPCRs, drug
development and therapeutics depend on gaining a better understanding of the intracellular fate of GPCRs.
Early endosomes comprise distinct compartments identified primarily
through studies of trafficking of the transferrin receptor (TfnR), a
single transmembrane receptor that constitutively internalizes. At
steady state, the TfnR resides in perinuclear recycling endosomes that
are distinguished from other endosomes by selective retention of
recycling proteins and the presence of the small GTPase Rab11a (Hopkins
et al., 1994 ; Ullrich et al., 1996 ; Green et al., 1997 ). Rab11a
(Ullrich et al., 1996 ; Ren et al., 1998 ) and myosin Vb, a member of the
class V unconventional myosins (Lapierre et al., 2001 ) that interacts
with Rab11a, are involved in TfnR recycling to the plasma membrane.
Although mechanisms involved in agonist-induced GPCR endocytosis have
been extensively characterized, less is known about the intracellular
pathways and molecules involved in GPCR recycling. The mechanisms
mediating GPCR recycling may be distinct from those for the
constitutively recycling TfnR (Cao et al., 1999 ). Also, different GPCR
subtypes show distinct endocytic trafficking patterns (Trejo and
Coughlin, 1999 ; Anburgh et al., 2000 ; Krudewig et al., 2000 ; Tsao and
von Zastrow, 2000 ; Innamorati et al., 2001 ). Given the central role
that GPCR recycling plays in regulating cellular responses to ligand,
it is critical to identify the mechanisms that control GPCR recycling.
Furthermore, because the mechanisms that control TfnR trafficking do
not necessarily generalize to GPCRs and because the different GPCR
subtypes show distinct endocytic pathways, it is crucial to
characterize the intracellular trafficking of individual GPCR subtypes.
We examined the pathways responsible for the recycling of the
M4 muscarinic ACh receptor (mAChR).
M4 is highly expressed in the CNS (Levey et al.,
1991 ; Hersch et al., 1994 ), is the primary autoreceptor in the
striatum, plays a role in locomotor activity (Gomeza et al., 1999 ), and
is a novel therapeutic target for schizophrenia (Felder et al., 2001 )
and Alzheimer's disease (Bodick et al., 1997 ). Activated
M4 internalizes to endosomes in cell culture and
the rat brain, and M4 recycling to the plasma
membrane is required for resensitization (Bogatkewitsch et al., 1996 ;
Bernard et al., 1999 ; Volpicelli et al., 2001 ). To define the
mechanisms that control receptor recycling, we studied the endogenously
expressed M4 mAChR in neuronotypic PC12 cells
(Berkeley and Levey, 2000 ). This study identifies Rab11a and myosin Vb
as critical regulators of GPCR return to the plasma membrane.
 |
MATERIALS AND METHODS |
cDNA constructs. The Rab11aS25N construct was a
generous gift from Dr. Marino Zerial (Max Planck Institute for
Molecular Cell Biology and Genetics, Dresden, Germany) (Ullrich
et al., 1996 ). To construct the GFP-Rab11aS25N plasmid, the Rab11aS25N
cDNA was amplified by PCR with a 5' primer
(5'-TTATATCTCGAGAATGGGCACCCGCGA-3') that introduced a XhoI
restriction enzyme site and a 3' primer (5'-CGCGCGGAATTCGCCTTATATGTTCTG-3') that introduced an
EcoRI restriction enzyme site. The products were digested
and ligated into the pEGFP-C2 (Clontech, Palo Alto, CA) vector. The
sequence of the Rab11aS25N construct was confirmed by MWG Biotech (High
Point, NC). The myosin Vb tail-GFP construct has been described
previously (Lapierre et al., 2001 ).
Cell culture and transfections. PC12 cells were maintained
at 37°C and 5% CO2 in DMEM (Mediatech,
Herndon, VA) containing 10% heat-inactivated horse serum
(Invitrogen, Grand Island, NY), 5% fetal clone serum (HyClone,
Logan, UT), and 1% penicillin-streptomycin. Cells grown in six-well
trays were transfected with 1 µg of plasmid DNA using LipofectAMINE
2000 (Invitrogen, Carlsbad, CA). Approximately 5 hr after the
transfection, the cells were rinsed three times with PBS and passaged
onto Matrigel-coated coverslips in six-well trays. Immunocytochemistry
was performed 2 d after transfections.
Analysis of M4 recycling. To
selectively examine the proportion of internalized receptors that
return to the cell surface, newly synthesized receptors were eliminated
by 30 min pretreatment with cycloheximide (20 µg/ml) (Szekeres et
al., 1998 ). Cycloheximide was also included in all subsequent drug
treatments. Cells were treated with media containing 100 µM carbachol (CCh) for 60 min to induce
M4 internalization. The dishes were then placed
on ice, rinsed two times with chilled DMEM, returned to 37°C, and
incubated with media containing cycloheximide for various time points.
To calculate M4 recycling, the percentage of
M4 colocalization with cell surface
Na+/K+ ATPase
after CCh washout was quantified (see below) and normalized to cell
surface M4 in untreated cells. The residual cell
surface M4 remaining after 60 min CCh treatment
was then subtracted from this value to obtain the amount of
M4 that recovers to the cell surface after CCh
treatment and washout.
Immunocytochemistry. Cells were fixed for 30 min with 2%
paraformaldehyde in 0.1 M phosphate buffer, pH
7.3 and rinsed several times with PBS containing 0.5 normal
horse serum (PBS+). The cells were blocked
with PBS containing 5% normal horse serum and 1% bovine serum albumin
(blocking buffer) and permeabilized with 0.05% Triton X-100. The cells
were rinsed several times with PBS+ and
incubated in primary antibody diluted in blocking buffer overnight at
4°C. For double labeling, both primaries were included in the
incubation. The following primary antibodies were used: early endosome
autoantigen 1 (EEA1) mouse monoclonal (1:250; Transduction Laboratories, Lexington KY); M4 mouse monoclonal
(1:500; Chemicon, Temecula, CA) (Bernard et al., 1999 ) or rabbit
polyclonal (0.5 µg/ml) (Levey et al., 1991 );
Na+/K+ ATPase
-1 subunit mouse monoclonal (1:500; Upstate Biotechnology, Lake
Placid, NY); Rab4 rabbit polyclonal (1:500; Biosource, Camarillo, CA),
Rab7 rabbit polyclonal (1:100) (Chavrier et al., 1990 ), or Rab11 rabbit
polyclonal (1:500; Zymed, San Francisco, CA); and TfnR mouse monoclonal
(1:500; Zymed). The cells were rinsed and incubated for 60 min with
rhodamine red-X or Cy5-conjugated donkey anti-rabbit or mouse secondary
antibodies diluted in blocking buffer (1:100; Jackson ImmunoResearch,
West Grove, PA). Both secondary antibodies were included in the
incubation. The cells were then rinsed and mounted onto slides with
Vectashield mounting medium (Vector Laboratories, Burlingame, CA). The
cells were scanned with a Zeiss (Heidelberg, Germany) LSM 510 laser
scanning confocal microscope as described previously (Volpicelli et
al., 2001 ), and the images were prepared using Adobe Photoshop (Adobe
Systems, San Jose, CA).
Quantitation of colocalization. MetaMorph imaging system
software (Universal Imaging Corporation, West Chester, PA) was used to
quantitate colocalization on unprocessed images as described previously
(Volpicelli et al., 2001 ). Briefly, background was subtracted from the
images, and the percentage of overlapping pixels between
M4 and
Na+/K+ ATPase
(or other markers) pixels was determined. Unless indicated otherwise,
for each time point, eight cells from three experiments were analyzed
for n = 24. All data were analyzed by independent samples t test or ANOVA and Fisher's least significant
difference post hoc test.
Binding assays. After drug treatments, cells plated on
six-well trays were rinsed three times with 2 ml of cold HBSS
(Mediatech) and incubated overnight at 4°C with 1 nM 3H-quinuclidinyl
benzilate (QNB) or 1 nM
3H-N-methyl-scopolamine (NMS).
Nonspecific binding was determined using 20 µM
atropine. The cells were transferred to polystyrene culture tubes and
filtrated through Whatman GF/B fired glass-fiber filters. Filters were
rinsed three times with cold PBS, and radioactivity was determined by
liquid scintillation spectroscopy.
 |
RESULTS |
After prolonged agonist stimulation, M4 traffics to a
TfnR-positive perinuclear compartment
In nonpolarized cells, the constitutively endocytosed and recycled
TfnR localizes to a perinuclear compartment defined as recycling
endosomes (Hopkins et al., 1994 ). To begin to study the role of this
endosomal compartment in M4 recycling, we
determined whether M4 colocalizes with the TfnR
after sustained agonist stimulation (Fig.
1A). In untreated PC12
cells, M4 localized primarily to the cell
surface, whereas the TfnR showed a concentrated localization near the
nucleus. Brief stimulation with CCh (10 min) resulted in
M4 internalization to peripherally distributed
early endosomes (Volpicelli et al., 2001 ). After prolonged (60 min) CCh
stimulation, M4 internalized from the cell
surface and showed a perinuclear localization similar to the TfnR.
M4 and the TfnR colocalized extensively in this
perinuclear endosomal compartment, indicating that
M4 traveled to a similar recycling endosomal
compartment as the TfnR after agonist stimulation. Quantitation of the
confocal images revealed minimal colocalization of
M4 with the TfnR in untreated cells and a
significant increase of M4 overlap with TfnR
after 60 min prolonged CCh treatment.

View larger version (30K):
[in this window]
[in a new window]
|
Figure 1.
After agonist stimulation, M4 traffics
to a perinuclear compartment, in which it colocalizes with the TfnR.
A, In untreated PC12 cells, M4
(red) localized to the cell surface, and the TfnR
(green) showed a primarily perinuclear
distribution. After 60 min continuous CCh treatment, M4
redistributed from the cell surface to the perinuclear compartment, in
which it colocalized extensively with the TfnR (visualized as
yellow in the merged images). The inset
shows a higher-magnification image of the perinuclear compartment,
demonstrating that the majority of internalized M4
colocalized with the TfnR. Scale bar, 10 µm. B,
Quantitation of confocal images demonstrated that M4 showed
minimal colocalization with TfnR in untreated cells
(n = 11), and, after 60 min CCh treatment,
M4 overlap with TfnR was significantly enhanced
(n = 16). ***p < 0.001.
|
|
After agonist washout, M4 returns to the
cell surface
After prolonged CCh treatment, M4 may either
recycle to the cell surface or be targeted to lysosomes for
degradation. We therefore determined whether internalized
M4 returns to the cell surface after agonist
washout. To distinguish receptors that recycle to the cell surface
after agonist treatment and internalization from newly synthesized
receptors, cells were pretreated with cycloheximide to prevent new
protein synthesis. In nonstimulated cells, M4
showed colocalization with the cell surface marker
Na+/K+ ATPase
(Fig. 2A). After CCh
treatment, internalized M4 resided near the
nucleus and showed minimal overlap with the
Na+/K+
ATPase. However, by 60 min of CCh washout, M4
returned to the cell surface, in which it colocalized with the
Na+/K+
ATPase. A portion of M4 remained in an
intracellular localization 60 min after CCh washout.

View larger version (36K):
[in this window]
[in a new window]
|
Figure 2.
M4 returns to the cell
surface after agonist stimulation and washout. To selectively examine
the amount of M4 that recycles to the cell surface after
CCh treatment and washout, cells were treated with cycloheximide to
prevent new receptor synthesis, and cycloheximide was included in all
subsequent drug treatments. A, Cells were untreated,
treated continuously with CCh for 60 min, or treated with CCh for 60 min, rinsed, and incubated in media alone for 60 min to allow
M4 recovery to the cell surface. In untreated cells,
M4 (red) localized primarily to the cell
surface, but a small proportion of receptors also showed an
intracellular localization. Cell surface M4 colocalized
(yellow in the merged image) with the plasma
membrane marker Na+/K+ ATPase
(green). The inset shows a
higher-magnification image of the cell surface, demonstrating that,
although M4 showed colocalization with the
Na+/K+ ATPase
(yellow), subdomains exist at the cell surface
that contain M4 but not the
Na+/K+ ATPase
(red). Although all cells show staining for the
Na+/K+ ATPase, not all PC12 cells
show M4 staining, demonstrating heterogeneity of
M4 receptor expression in PC12 cells. After 60 min
continual CCh treatment, M4 trafficked from the cell
surface to perinuclear endosomes and no longer colocalized with
Na+/K+ ATPase. After 60 min CCh
treatment followed by 60 min washout, M4 returned to the
cell surface, in which it colocalized with the
Na+/K+ ATPase. A proportion of
receptors also showed an intracellular distribution. Scale bars, 10 µm. B, Measurements of M4 recycling using
quantitative immunocytochemistry were compared with measurements of
mAChR recycling using 3H-NMS. Cells were treated with CCh,
rinsed, and incubated in media alone for 60 or 90 min. The amounts of
cell surface receptors measured using both assays after CCh washout
were normalized to the amounts of cell surface receptors in untreated
cells (black bars and cross-hatched
bars). When expressed as a percentage of untreated cells, the
extent of M4 recycling measured by quantitative
immunocytochemistry was slightly higher than the extent of recycling
measured by binding assays. Subtracting the residual M4
remaining after 60 min CCh treatment, however, produced values for
M4 recycling using confocal images (gray
bars) that were similar to measurements of mAChR recycling
using binding assays. This method of calculating M4
recycling in confocal images was thus used throughout the remainder of
the paper. C, The amount of M4 recovery to
the cell was quantified using confocal images at various time points
after CCh washout. The graph demonstrates that M4 began to
return to the cell surface as early as 15 min after agonist washout,
and, 3 hr after washout, the majority of M4 (visible by
immunocytochemistry) localized to the cell surface.
|
|
To quantitate recycling after agonist washout, M4
overlap with the cell surface marker
Na+/K+ ATPase
was measured on confocal images. Using this method to quantify
M4 internalization in single cells has been
established previously and shown to provide results similar to
measurements of internalization use binding assays with the membrane
impermeant, nonselective mAChR ligand
3H-NMS (Volpicelli et al., 2001 ). We first
compared the extent of M4 recycling measured by
quantitative immunocytochemistry with binding assays using
3H-NMS (Fig. 2B). Cells
were treated with CCh for 60 min, rinsed, and incubated in media alone
for 60 or 90 min. When the recycling data obtained from confocal images
and binding assays were expressed as a percentage of untreated cells,
the extent of M4 recycling measured by
quantitative immunocytochemistry was slightly higher than binding assay
measurements. It is possible that measuring the percentage of
M4 pixels that overlap with the
Na+/K+ ATPase
after CCh treatment and washout included receptors that are at or near
the cell surface but cannot bind ligand. When the cell surface
M4 remaining after 60 min CCh treatment was
subtracted from the value of cell surface M4
after CCh washout, the values for M4 recycling
were equivalent to binding assays. Therefore, quantitative
immunocytochemistry provides a valid measure of
M4 recycling after agonist stimulation and
washout, and this method of calculating M4
recycling was used for all of the analysis throughout the paper.
Furthermore, unlike binding assays, confocal microscopy allows
visualization of M4 localization to specific
intracellular compartments.
Quantitative immunocytochemistry was then used to analyze a more
extensive time course of M4 recycling (Fig.
2C). M4 began to recycle to the plasma
membrane as early as 15 min after CCh washout, and, by 3 hr, the vast
majority of detectable M4 had returned to the
cell surface (t1/2 = 60 min).
It is possible that two sources of intracellular of
M4 could contribute to the reappearance of
M4 to the cell surface: M4 internalized after agonist stimulation and a pool of intracellular M4 that existed at baseline. We therefore
measured the numbers of cell surface mAChRs (using the
membrane-impermeant ligand 3H-NMS) and
total mAChRs (using the permeable ligand
3H-QNB). The vast majority (96%) of
mAChRs reside at the cell surface in untreated PC12 cells. Unlike
binding assays, confocal images show a proportion of intracellular
M4 in unstimulated cells (Fig. 2), and
measurements of pixel intensity reveal that ~20% of
M4 pixels represent an intracellular pool of
receptors. Intracellular M4 could reside in
acidic endosomes or lysosomes in which the receptor conformation is
altered, or the receptor is degraded such that it cannot be recognized
by ligand but can be recognized by the antibody. Prolonged treatment of
control PC12 cells with atropine to prevent M4
activation and internalization by endogenously released ACh does not
cause a statistically significantly increase of
M4 colocalization with the
Na+/K+ ATPase
(Volpicelli et al., 2001 ). Thus, the intracellular
M4 detected by immunofluorescence in unstimulated
cells does not traffic to the cell surface and therefore does not
substantially contribute to the reappearance of
M4 at the cell surface.
Although quantitative immunocytochemistry can analyze receptor
distribution within a cell (i.e., the percentage of detectable receptor
at the cell surface vs intracellular), it does not provide information
about possible changes in total receptor levels. Therefore, binding
assays using 3H-QNB, which binds to cell
surface and intracellular mAChRs, were performed to measure the extent
of mAChR degradation after CCh stimulation and washout. After 60 min
CCh treatment, total mAChR binding was unchanged (110 ± 15% of
untreated cells). Because M4 accounts for >95%
of total mAChR binding in PC12 cells (Berkeley and Levey, 2000 ), the
majority of M4 does not degrade after 60 min
continual CCh treatment. However, after 60 min CCh treatment followed
by 180 min washout, mAChR binding was 57 ± 4% of untreated cells. Therefore, after prolonged CCh treatment, ~40% of
M4 was targeted for degradation and the remaining
M4 returned to the cell surface.
Internalized M4 traffics to a Rab11a-positive
perinuclear compartment
In nonpolarized cells, Rab11a shows a perinuclear distribution
similar to internalized M4 and TfnR and plays a
role in TfnR recycling back to the cell surface in HeLa, CHO, and BHK
cells (Ullrich et al., 1996 ; Ren et al., 1998 ). We determined whether M4 also colocalized with Rab11a in the
TfnR-positive compartment of CCh-treated PC12 cells. Initially after
CCh stimulation (2.5 and 10 min), M4 began to
internalize from the cell surface, and the majority of
M4 localized to discrete puncta distributed
peripherally throughout the cell (Fig.
3A), shown previously to be
EEA1-positive endosomes (Volpicelli et al., 2001 ). Although the
majority of M4 did not colocalize with Rab11a
after 2.5 min of CCh stimulation, by 10 min CCh, a significant portion
of M4 accumulated near the nucleus, in which it
colocalized with Rab11a. After 60 min continual CCh treatment, the
majority of M4 colocalized with Rab11a in the perinuclear compartment. Quantitation of M4
colocalization with Rab11a (Fig. 3B) showed that the extent
of M4 colocalization with Rab11a progressively
increased over the time course of CCh treatment.

View larger version (25K):
[in this window]
[in a new window]
|
Figure 3.
After prolonged CCh stimulation, M4
colocalizes with Rab11a in the perinuclear compartment.
A, After 2.5 min continual CCh treatment, M4
(red) began to redistribute from the cell surface to
large puncta (arrowheads) that did not colocalize with
Rab11a (green). M4 began to
colocalize with Rab11a after 10 min CCh treatment (visualized as
yellow, arrow), and, after 60 min,
M4 colocalized extensively with Rab11a in the perinuclear
compartment. Scale bars, 10 µm. B, Quantitation of
confocal images demonstrated that M4 showed minimal
colocalization with Rab11a in untreated cells (n = 7) and after 2.5 min CCh stimulation (n = 4). By 10 min of continual CCh treatment (n = 9),
M4 overlap with Rab11a was significantly enhanced and
increased further after 60 min CCh treatment (n = 12). ***p < 0.001.
|
|
Perinuclear concentration of internalized M4 is
Rab11a dependent
To determine whether M4 trafficking to
perinuclear endosomes required Rab11a GTPase activity, we expressed, in
PC12 cells, the constitutively GDP-bound GFP-Rab11aS25N fusion protein,
which cannot exchange GDP for GTP. GFP-Rab11aS25N showed a diffuse, cytosolic distribution consistent with the inability of GDP-bound Rab
proteins to bind to the membrane (Ullrich et al., 1994 ) (Fig. 4A). In untreated PC12
cells, expression of GFP-Rab11aS25N had no effect on the localization
of M4 to the plasma membrane (data not shown). In
control cells transfected with the pEGFP vector, after 60 min CCh,
internalized M4 showed a perinuclear
localization. In cells expressing GFP-Rab11aS25N,
M4 localized to small puncta dispersed throughout
the cell and did not concentrate near the nucleus. Similarly,
expression of GFP-Rab11aS25N also dispersed the TfnR throughout the
cell compared with pEGFP vector-transfected control cells (Fig.
4B). M4 showed colocalization
with TfnR in vector-transfected control cells and in
Rab11aS25N-expressing cells. Quantitative immunocytochemistry revealed
that M4 colocalization with the TfnR in
vector-transfected cells (51 ± 3%; n = 16) was equivalent to GFP-Rab11aS25N-transfected cells (50 ± 4%;
n = 16; p = NS).

View larger version (37K):
[in this window]
[in a new window]
|
Figure 4.
Constitutively GDP-bound Rab11aS25N prevents
M4 accumulation in perinuclear recycling endosomes. Cells
were treated continuously with CCh for 60 min. A, In
control cells transfected with the pEGFP vector, GFP showed a diffuse,
ubiquitous distribution, and M4 (red)
localized to the perinuclear compartment. In cells transfected with
GFP-Rab11aS25N, GFP showed a diffuse, cytosolic distribution consistent
with the inability of GDP-bound Rab11aS25N to bind membrane. In
contrast to vector-transfected control cells, M4 in cells
expressing GFP-Rab11aS25N localized to small puncta distributed
throughout the cell and did not accumulate in the perinuclear
compartment. Scale bars, 10 µm. B, In pEGFP
vector-transfected control cells, M4 (red)
and TfnR (green) localized to the perinuclear
compartment. Expression of GFP-Rab11aS25N caused dispersal of both
M4 and TfnR to small puncta distributed throughout the
cell. M4 and TfnR showed colocalization in both
vector-transfected control cells and GFP-Rab11aS25N-expressing cells.
Scale bars, 10 µm.
|
|
It has been proposed that constitutively GDP-bound Rab11aS25N prevents
trafficking of the TfnR from early endosomes to perinuclear recycling
endosomes (Ullrich et al., 1996 ; Ren et al., 1998 ). Because
GFP-Rab11aS5N impairs M4 trafficking to
perinuclear endosomes, we sought to identify the peripheral vesicular
compartment containing M4 in cells expressing
this mutant. First, we analyzed the extent of M4
colocalization with the early endosome marker EEA1 (Rubino et al.,
2000 ). In both pEGFP-transfected and GFP-Rab11aS25N-expressing cells,
EEA1 localized to large puncta throughout the cell (Fig. 5A). However, in both cases,
after 60 min CCh treatment, we failed to observe significant overlap
between EEA1 and M4. Quantitative immunocytochemistry showed that M4 colocalization
with EEA1 in Rab11aS25N-expressing cells (19 ± 3%;
n = 16) was not increased compared with
vector-transfected control cells (22 ± 6%; n = 16; p = NS). If GFP-Rab11a S25N prevented trafficking
from EEA1-positive early endosomes, M4
colocalization with EEA1 would be enhanced relative to control cells.
However, although M4 shows a more dispersed localization in Rab11aS25N-expressing cells compared with
vector-transfected control cells, M4
colocalization with EEA1 is not enhanced. Therefore, M4 can exit from the EEA1-positive early
endosomal domain in cell expressing dominant negative Rab11aS25N.

View larger version (44K):
[in this window]
[in a new window]
|
Figure 5.
Constitutively GDP-bound Rab11aS25N does not
prevent M4 transit through early endosomes or enhance
M4 trafficking to late endosomes. Cells were treated
continuously with CCh for 60 min. A, In
vector-transfected control cells, the early endosomal marker EEA1
(green) localized to puncta distributed
peripherally throughout the cell, and M4 and EEA1 showed
minimal colocalization. In cells transfected with GFP-Rab11aS25N,
M4 localized to small puncta dispersed throughout the cell.
However, M4 and EEA1 showed little colocalization. Scale
bars, 10 µm. B, Rab4 (green)
localized to small puncta peripherally distributed throughout the cell.
M4 (red) showed minimal colocalization with
Rab4 in vector-transfected control cells and cells expressing
Rab11aS25N. Scale bars, 10 µm. C, The late endosomal
marker Rab7 localized to small puncta distributed throughout the cells.
In vector-transfected control cells, internalized M4 showed
some colocalization with Rab7. In cells expressing GFP-Rab11aS25N,
M4 colocalization with Rab7 was not enhanced. Scale bars,
10 µm.
|
|
Early endosomes are comprised of two domains: a Rab5a/EEA1 domain that
initially receives endocytosed material and a Rab4 domain. Rab4 is
involved in recycling of the TfnR and the -adrenergic receptor
directly from early endosomes (van der Sluijs et al., 1992 ; Seachrist
et al., 2000 ; Sonnichsen et al., 2000 ). It was thus possible that, in
the presence of GFP-Rab11aS25N, M4 could transit
from the EEA1-positive early endosomal domain to the Rab4-positive domain on early endosomes but fail to continue into perinuclear recycling endosomes. We thus determined whether GFP-Rab11aS25N expression enhanced M4 colocalization with Rab4.
In cells expressing inactive Rab11aS25N, the morphology of
Rab4-positive early endosomes was similar to pEGFP vector-transfected
control cells. In pEGFP vector-transfected control cells,
M4 showed ~46 ± 2% (n = 16) colocalization with Rab4 (Fig. 5B). Expression of
GFP-Rab11aS25N reduced M4 colocalization with
Rab4 (35 ± 2%; n = 16; p < 0.001). Therefore, expression of GFP-Rab11aS25N did not cause retention of M4 in either EEA1- or Rab4-positive early endosomes.
GFP-Rab11aS25N expression may enhance trafficking of
M4 to a late endosomal-degradative pathway. Rab7
plays a role in trafficking from early sorting endosomes to late
endosomes (Chavrier et al., 1990 ; Feng et al., 1995 ). Thus, if
targeting of M4 to late endosomes is enhanced by
GFP-Rab11aS25N expression, M4 colocalization with Rab7 should be enhanced. In vector-transfected cells (Fig.
5C), M4 showed a perinuclear
localization and Rab7 localized to small puncta throughout the cells.
The morphology of Rab7-positive endosomes did not appear to be altered
by expression of GFP-Rab11aS25N. Furthermore, colocalization of
M4 with Rab7 did not appear to be enhanced in
GFP-Rab11sS25N-expressing cells. M4
colocalization with Rab7 is 48 ± 2% (n = 16) in
control cells and 49 ± 1% (n = 16;
p = NS) in Rab11aS25N-expressing cells. Thus,
expression of inactive GFP-Rab11aS25N does not enhance targeting of
M4 to a Rab7-positive late endosomal pathway.
M4 recycling is Rab11a dependent
Because expression of dominant negative Rab11aS25N prevented
trafficking of M4 to perinuclear recycling
endosomes, we determined whether inhibiting Rab11a activity also
affected M4 recovery to the cell surface. In
contrast to control cells (Fig. 2), in GFP-Rab11aS25N-expressing cells, M4 distribution remained dispersed
throughout the cytosol and showed minimal return to the cell surface,
followed by 60 min CCh washout (Fig.
6A).

View larger version (31K):
[in this window]
[in a new window]
|
Figure 6.
Constitutively GDP-bound Rab11aS25N impairs
M4 recycling. Cells were treated with CCh for 60 min,
rinsed, and incubated in media alone for 60 or 180 min.
A, After CCh treatment and washout, in cells expressing
Rab11aS25N, M4 showed little recovery to the cell surface
compared with vector-transfected control cells and localized to small,
intracellular puncta. Scale bars, 10 µm. B, The amount
of M4 recovery to the cell surface was measured by
quantitation of confocal images, and the percentage of inhibition of
M4 recycling by Rab11aS25N was calculated relative to
vector-transfected control cells. M4 recycling was
dramatically inhibited by Rab11aS25N expression 60 min after agonist
washout. However, M4 eventually returned to the cell
surface 3 hr after agonist washout such that the percentage of
inhibition of M4 recycling was minimal after this prolonged
time point.
|
|
To quantitate M4 recycling, the percentage of
M4 that colocalized with the
Na+/K+ ATPase
was measured on confocal images. Because of low transfection efficiency
in PC12 cells, measurements of the effects of mutant Rab11a expression
would not normally be possible using traditional methods, such as
binding assays or cell surface biotinylation. However, quantitative
immunocytochemistry in single cells revealed that GFP-Rab11aS25N
expression had a dramatic effect on M4 recycling. Expression of GFP-Rab11aS25N inhibited M4
recycling after CCh stimulation and 60 min washout relative to
vector-transfected control cells (p < 0.001)
(Fig. 6B). However, the inhibition was not complete,
and, by 180 min, M4 eventually returned to the
cell surface. Quantitative immunocytochemistry revealed that the extent of cell surface M4 in GFP-Rab11aS25N-expressing
cells was similar to vector-transfected control cells 180 min after CCh
washout (p = NS). The inhibition of
M4 recycling was specific for inhibition of
Rab11a activity and not a result of general overexpression of Rab
proteins because expression of dominant negative Rab5a does not affect
the extent M4 recycling (data not shown). These findings indicate that Rab11a GTPase activity plays an important role
in the normal recovery of M4 to the cell surface.
The myosin Vb tail enhances concentration of M4 in
perinuclear endosomes
Recent studies have demonstrated that the active GTP-bound form of
Rab11a can interact with the C-terminal tail domain of myosin Vb, and
overexpression of a myosin Vb tail construct lacking its motor domain
inhibits recycling of TfnR out of the perinuclear compartment in HeLa
cells (Lapierre et al., 2001 ). Therefore, because
M4 recycling requires Rab11a activity, we
determined whether myosin Vb also plays a role in
M4 return to the cell surface. PC12 cells were
transfected with a GFP-myosin Vb tail construct that contains the
Rab11a binding domain but lacks the myosin Vb motor domain. Consistent
with previous findings (Lapierre et al., 2001 ), GFP-myosin Vb tail
showed a concentrated localization near the nucleus (Fig.
7A). At baseline, the
expression of the myosin Vb tail enhanced M4
intracellular localization. To quantitate the effect of myosin Vb tail
expression on the proportion of intracellular M4,
the percentage of cell surface M4 that
colocalized with the Na+/K+ ATPase
was measured. In untreated cells, M4 showed a
small but statistically significant 11% decrease in colocalization
with the
Na+/K+ ATPase
in cells expressing the myosin Vb tail compared with vector-transfected control cells (p < 0.01). These results are
consistent with previous findings that M4 shows a
small amount of atropine-sensitive endocytic activity at baseline
resulting from basal release of ACh (Volpicelli et al., 2001 ).

View larger version (29K):
[in this window]
[in a new window]
|
Figure 7.
The myosin Vb tail enhances M4
accumulation in perinuclear endosomes. A, Myosin Vb
tail-GFP showed a concentrated, perinuclear localization. In untreated
cells expressing the myosin Vb tail, M4
(red) localized to the cell surface but also showed some
accumulation intracellularly. Scale bar, 10 µm. B,
Expression of the myosin Vb tail enhanced M4 concentration
in the perinuclear compartment after 60 min CCh treatment. The
TfnR (blue) also showed enhanced accumulation in the
perinuclear compartment, and M4, the TfnR, and the
myosin Vb tail (green) colocalized extensively
(visualized as white in the merged image). Scale bar, 10 µm.
|
|
After 60 min CCh treatment, M4 showed enhanced
concentration in perinuclear endosomes in cells expressing the myosin
Vb tail relative to control cells (Fig. 1), and
M4 showed extensive colocalization with the
GFP-myosin Vb tail (Fig. 7B). Expression of the myosin Vb
tail also significantly enhanced M4
colocalization with the TfnR relative to vector-transfected control
cells. M4 colocalization with the TfnR in
vector-transfected control cells was 51 ± 3% compared with
71 ± 3% (p < 0.001) in myosin Vb
tail-expressing cells. Thus, the dominant negative myosin Vb tail
enhances M4 accumulation in perinuclear recycling endosomes.
The myosin Vb tail inhibits M4 recycling
Previous studies have suggested that expression of the myosin Vb
tail inhibits transit of recycling cargo out from the perinuclear compartment back to the cell surface (Lapierre et al., 2001 ). We
therefore determined the effects of GFP-myosin Vb tail expression on
recycling. As expected, M4 returned to the cell
surface after 60 min CCh treatment and 60 min washout in
vector-transfected control cells. However, in GFP-myosin Vb
tail-expressing cells, the majority of M4 was
retained in the perinuclear compartment with little recovery by 60 min
washout (Fig. 8A). The
dramatic ability of dominant negative myosin Vb tail to inhibit
M4 recycling was apparent as early as 15 min
after CCh washout and remained for up to 3 hr (Fig.
8B). Quantitation of the percentage of
M4 recycling after agonist treatment and washout
showed that GFP-myosin Vb tail expression significantly inhibited
M4 recycling relative to vector-transfected
control cells at 15, 60, and 180 min after CCh washout
(p < 0.001). Therefore, the myosin Vb tail
concentrated M4 in perinuclear endosomes and
functionally impeded M4 trafficking back to the
cell surface, indicating that myosin Vb plays a key role in
M4 recycling.

View larger version (26K):
[in this window]
[in a new window]
|
Figure 8.
The myosin Vb tail prevents M4
recycling. A, Cells were treated with CCh for 60 min,
rinsed, and incubated in media alone for 60 min. As expected, in
vector-transfected control cells, M4 returned to the cell
surface. In cells expressing the myosin Vb tail, the majority of
M4 remained in perinuclear recycling endosomes, although a
small amount of M4 returned to the cell surface. Scale
bars, 10 µm. B, The amount of M4 recovery
to the cell surface was measured by quantitation of confocal images,
and the percentage of inhibition of M4 recycling by the
myosin Vb tail was calculated relative to vector-transfected control
cells. Expression of the myosin Vb tail dramatically inhibited
M4 recycling 15 min after CCh washout. M4
recycling remained impaired by the myosin Vb tail for 60 min and as
long as 180 min after CCh washout.
|
|
 |
DISCUSSION |
After agonist stimulation and internalization, the dynamic
regulation of GPCR responsiveness after agonist stimulation is determined by a balance between degradation and recycling. Although the
molecular mechanisms regulating GPCR internalization have received
extensive study, the molecules involved in targeting GPCRs to the
recycling pathway have only received attention recently. We show that,
during prolonged agonist stimulation, M4
accumulates in perinuclear endosomes, in which it colocalizes with TfnR
and Rab11a. Expression of mutant forms of Rab11a and myosin Vb
dramatically impair M4 recycling. Thus, the
results presented here indicate that M4 receptors
traffic through a specific recycling pathway through mechanisms
dependent on both Rab11a and myosin Vb.
Previously, we demonstrated that, initially after agonist-induced
internalization, M4 traffics to peripherally
distributed Rab5a-positive early endosomes (Volpicelli et al., 2001 ).
We now extend these findings by showing that, with prolonged
stimulation, M4 traffics from early endosomes to
perinuclear recycling endosomes, in which it colocalizes with the TfnR
and Rab11a, markers for the perinuclear recycling compartment (Hopkins
and Trowbridge, 1983 ; Yamashiro et al., 1984 ; Hopkins et al., 1990 ,
1994 ; Ghosh et al., 1994 ; Ullrich et al., 1996 ; Green et al., 1997 ; Ren
et al., 1998 ; Casanova et al., 1999 ; Sonnichsen et al., 2000 ; Wang et
al., 2001 ). Rab11a activity is required for M4
recycling because expression of the constitutively GDP-bound form of
Rab11a, Rab11aS25N, alters M4 trafficking through
the recycling pathway and severely impairs M4
recycling after CCh washout. Other GPCRs localize to perinuclear
endosomes after internalization (von Zastrow and Kobilka, 1992 ; Tolbert
and Lameh, 1996 ), and some subtypes have been shown to colocalize with
Rab11a (Moore et al., 1999 ; Innamorati et al., 2001 ; Kreuzer et al.,
2001 ; Hunyady et al., 2002 ). Our study is the first to demonstrate that
recycling of the M4 subtype of GPCR requires
Rab11a activity and indicates that the perinuclear endosomal compartment may be a common recycling pathway for multiple GPCR subtypes.
After internalization to early endosomes, receptors targeted for
recycling traffic to perinuclear recycling endosomes (Mellman, 1996 ).
In cells expressing Rab11aS25N, M4 does not
accumulate in perinuclear endosomes but localizes to small puncta with
a vesicular appearance dispersed throughout the cell. Studies in nonpolarized cells suggest that Rab11aS25N impairs recycling by preventing receptor traffic from early endosomes (Ullrich et al., 1996 ;
Ren et al., 1998 ). Thus, M4 should accumulate in
early endosomes in cells expressing Rab11aS25N, within either an
EEA1-positive domain or a Rab4 domain. However, our results demonstrate
that internalized M4 does not show enhanced
colocalization with EEA1 or Rab4 in Rab11aS25N-expressing cells.
Therefore, unlike the TfnR, in this cell system, inactivation of Rab11a
does not appear to prevent M4 transit from early
endosomes. Expression of Rab11aS5N also does not enhance
M4 colocalization with Rab7 and therefore Rab11aS5N does not enhance M4 trafficking to a
late endosomal-degradative pathway. Furthermore, because the cells
were treated with the protein synthesis inhibitor cycloheximide,
M4 localization to biosynthetic compartments is
minimal. However, M4 does show colocalization with the TfnR in Rab11aS25N-expressing cells, identifying this compartment as an early endosomal compartment. These data thus suggest
that M4 traffics from early endosomes to
recycling endosomes via an intermediate vesicular-early endosomal
compartment and that active Rab11a is required for trafficking of these
intermediate vesicles to perinuclear recycling endosomes. An
alternative explanation is that, in cells expressing Rab11aS25N,
M4 traffics to recycling endosomes, but
accumulation of tubules-vesicles near the nucleus is prevented.
Inhibition of Rab11a activity could also alter recycling system
morphology by blocking association of vesicles with Rab11a effectors,
(Prekeris et al., 2000 , 2001 ; Hales et al., 2001 ), including
interaction with the myosin Vb motor protein (Lapierre et al.,
2001 ).
Myosin Vb is an effector molecule that selectively interacts with the
active GTP-bound Rab11a but not Rab11aS25N (Lapierre et al., 2001 ).
Myosin Vb contains a tail domain that binds Rab11a, a neck domain
containing calmodulin binding motifs and a motor head domain.
Expression of the myosin Vb tail causes inhibition of TfnR recycling in
HeLa cells, as well as basolateral to apical transcytosis and apical
recycling in polarized Madin-Darby canine kidney cells (Lapierre
et al., 2001 ). In this study, expression of the myosin Vb tail enhances
accumulation of M4 in the perinuclear compartment
and inhibits recycling, even at prolonged time points after agonist
washout. Thus, in myosin Vb tail-expressing cells, Rab11a-positive
vesicles containing M4 can accumulate in the
perinuclear compartment, but they cannot exit because myosin Vb cannot
mobilize vesicles out of perinuclear compartment back to cell surface. Integrity of the actin cytoskeleton is necessary for targeting GPCRs to
the recycling pathway. For example, disrupting the actin cytoskeleton
targets the -adrenergic receptor to the degradative pathway (Cao et
al., 1999 ). Although we did not address the fate of
M4 in myosin Vb tail-expressing cells because of
low transfection efficiency in PC12 cells, it is possible that
preventing myosin Vb interaction with the actin cytoskeleton would
prevent sorting of M4 to recycling pathway and
enhance M4 degradation. Regardless of the
mechanism by which myosin Vb directs M4
trafficking back to the cell surface, we show for the first time that a
specific motor protein is involved in GPCR recycling.
In summary, after agonist stimulation, M4
internalizes from the cell surface sequentially to Rab5a-positive early
endosomes (Volpicelli et al., 2001 ) and then through a recycling
endosomal system containing Rab11a and myosin Vb. Active Rab11a and
myosin Vb are required for recycling of vesicles containing
M4 back to the cell surface, likely mediated in
part via an interaction between myosin Vb and the actin cytoskeleton.
M4 plays an important role in locomotor activity
(Gomeza et al., 1999 ), as the primary cholinergic autoreceptor in the
striatum (Zhang et al., 2002 ) and as a target for the treatment of
Alzheimer's disease (Bodick et al., 1997 ). Rab11a and myosin Vb are
expressed in the brain (Sheehan et al., 1996 ; Zhao et al., 1996 ), and,
thus, identifying that Rab11a and myosin Vb play key roles in
M4 recycling helps to understand the mechanisms
by which neurons may maintain responsiveness to ACh stimulation.
Overall, these studies indicate that specific trafficking pathways
serve to direct the accurate recycling of particular GPCRs to the
plasma membrane.
 |
FOOTNOTES |
Received July 17, 2002; revised Sept. 9, 2002; accepted Sept. 11, 2002.
This work was supported by the Alzheimer's Association (A.I.L.), a
Pharmaceutical Research and Manufacturers Association Foundation Advanced Predoctoral Fellowship (L.A.V.), National Institutes of Health
Grant RO1 NS30454 (A.I.L.), National Institutes of
Health/National Institute of Diabetes and Digestive and Kidney Diseases
Grants DK48370 and DK43405, and a Veterans Administration Merit Award (J.R.G.).
Correspondence should be addressed to Dr. A. I. Levey, Center for
Neurodegenerative Disease, Emory University School of Medicine, Whitehead Biomedical Research Building, 615 Michael Street, Fifth Floor, Atlanta, GA 30322. E-mail: alevey{at}emory.edu.
 |
REFERENCES |
-
Anborgh PH,
Seachrist JL,
Dale LB,
Ferguson SS
(2000)
Receptor/beta-arrestin complex formation and the differential trafficking and resensitization of beta2-adrenergic and angiotensin II type 1A receptors.
Mol Endocrinol
14:2040-2053[Abstract/Free Full Text].
-
Berkeley JL,
Levey AI
(2000)
Muscarinic activation of mitogen-activated protein kinase in PC12 cells.
J Neurochem
75:487-493[Web of Science][Medline].
-
Bernard V,
Levey AI,
Bloch B
(1999)
Regulation of the subcellular distribution of m4 muscarinic acetylcholine receptors in striatal neurons in vivo by the cholinergic environment: evidence for regulation of cell surface receptors by endogenous and exogenous stimulation.
J Neurosci
19:10237-10249[Abstract/Free Full Text].
-
Bloch B,
Dumartin B,
Bernard V
(1999)
In vivo regulation of intraneuronal trafficking of G protein-coupled receptors for neurotransmitters.
Trends Pharmacol Sci
20:315-319[Medline].
-
Bodick NC,
Offen WW,
Levey AI,
Cutler NR,
Gauthier SG,
Satlin A,
Shannon HE,
Tollefson GD,
Rasmussen K,
Bymaster FP,
Hurley DJ,
Potter WZ,
Paul SM
(1997)
Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease.
Arch Neurol
54:465-473[Abstract/Free Full Text].
-
Bogatkewitsch GS,
Lenz W,
Jakobs KH,
Van Koppen CJ
(1996)
Receptor internalization delays m4 muscarinic acetylcholine receptor resensitization at the plasma membrane.
Mol Pharmacol
50:424-429[Abstract].
-
Cao TT,
Deacon HW,
Reczek D,
Bretscher A,
von Zastrow M
(1999)
A kinase-regulated PDZ-domain interaction controls endocytic sorting of the beta2-adrenergic receptor.
Nature
401:286-290[Medline].
-
Carroll RC,
Beattie EC,
von Zastrow M,
Malenka RC
(2001)
Role of AMPA receptor endocytosis in synaptic plasticity.
Nat Rev Neurosci
2:315-324[Web of Science][Medline].
-
Casanova JE,
Wang X,
Kumar R,
Bhartur SG,
Navarre J,
Woodrum JE,
Altschuler Y,
Ray GS,
Goldenring JR
(1999)
Association of Rab25 and Rab11a with the apical recycling system of polarized Madin-Darby canine kidney cells.
Mol Biol Cell
10:47-61[Abstract/Free Full Text].
-
Chavrier P,
Parton RG,
Hauri HP,
Simons K,
Zerial M
(1990)
Localization of low molecular weight GTP binding proteins to exocytic and endocytic compartments.
Cell
62:317-329[Web of Science][Medline].
-
Felder CC,
Porter AC,
Skillman TL,
Zhang L,
Bymaster FP,
Nathanson NM,
Hamilton SE,
Gomeza J,
Wess J,
McKinzie DL
(2001)
Elucidating the role of muscarinic receptors in psychosis.
Life Sci
68:2605-2613[Web of Science][Medline].
-
Feng Y,
Press B,
Wandinger-Ness A
(1995)
Rab 7: an important regulator of late endocytic membrane traffic.
J Cell Biol
131:1435-1452[Abstract/Free Full Text].
-
Finn AK,
Whistler JL
(2001)
Endocytosis of the mu opioid receptor reduces tolerance and a cellular hallmark of opiate withdrawal.
Neuron
32:829-839[Web of Science][Medline].
-
Ghosh RN,
Gelman DL,
Maxfield FR
(1994)
Quantification of low density lipoprotein and transferrin endocytic sorting HEp2 cells using confocal microscopy.
J Cell Sci
107:2177-2189[Abstract].
-
Gomeza J,
Zhang L,
Kostenis E,
Felder C,
Bymaster F,
Brodkin J,
Shannon H,
Xia B,
Deng C,
Wess J
(1999)
Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M(4) muscarinic acetylcholine receptor knockout mice.
Proc Natl Acad Sci USA
96:10483-10488[Abstract/Free Full Text].
-
Green EG,
Ramm E,
Riley NM,
Spiro DJ,
Goldenring JR,
Wessling-Resnick M
(1997)
Rab11 is associated with transferrin-containing recycling compartments in K562 cells.
Biochem Biophys Res Commun
239:612-616[Web of Science][Medline].
-
Hales CM,
Griner R,
Hobdy-Henderson KC,
Dorn MC,
Hardy D,
Kumar R,
Navarre J,
Chan EK,
Lapierre LA,
Goldenring JR
(2001)
Identification and characterization of a family of Rab11-interacting proteins.
J Biol Chem
276:39067-39075[Abstract/Free Full Text].
-
He L,
Fong J,
von Zastrow M,
Whistler JL
(2002)
Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization.
Cell
108:271-282[Web of Science][Medline].
-
Hersch SM,
Gutekunst CA,
Rees HD,
Heilman CJ,
Levey AI
(1994)
Distribution of M1-M4 muscarinic receptor proteins in the rat striatum: light and electron microscopic immunocytochemistry using subtype-specific antibodies.
J Neurosci
14:3351-3363[Abstract].
-
Hopkins CR,
Trowbridge IS
(1983)
Internalization and processing of transferrin and the transferrin receptor in human carcinoma A431 cells.
J Cell Biol
97:508-521[Abstract/Free Full Text].
-
Hopkins CR,
Gibson A,
Shipman M,
Miller K
(1990)
Movement of internalized ligand-receptor complexes along a continuous endosomal reticulum.
Nature
346:335-339[Medline].
-
Hopkins CR,
Gibson A,
Shipman M,
Strickland DK,
Trowbridge IS
(1994)
In migrating fibroblasts, recycling receptors are concentrated in narrow tubules in the pericentriolar area, and then routed to the plasma membrane of the leading lamella.
J Cell Biol
125:1265-1274[Abstract/Free Full Text].
-
Hunyady L,
Baukal AJ,
Gaborik Z,
Olivares-Reyes JA,
Bor M,
Szaszak M,
Lodge R,
Catt KJ,
Balla T
(2002)
Differential PI 3-kinase dependence of early and late phases of recycling of the internalized AT1 angiotensin receptor.
J Cell Biol
157:1211-1222[Abstract/Free Full Text].
-
Innamorati G,
Le Gouill C,
Balamotis M,
Birnbaumer M
(2001)
The long and the short cycle. Alternative intracellular routes for trafficking of G-protein-coupled receptors.
J Biol Chem
276:13096-13103[Abstract/Free Full Text].
-
Koenig JA,
Edwardson JM
(1997)
Endocytosis and recycling of G protein-coupled receptors.
Trends Pharmacol Sci
18:276-287[Medline].
-
Kreuzer OJ,
Krisch B,
Dery O,
Bunnett NW,
Meyerhof W
(2001)
Agonist-mediated endocytosis of rat somatostatin receptor subtype 3 involves beta-arrestin and clathrin coated vesicles.
J Neuroendocrinol
13:279-287[Web of Science][Medline].
-
Krudewig R,
Langer B,
Vogler O,
Markschies N,
Erl M,
Jakobs KH,
van Koppen CJ
(2000)
Distinct internalization of M2 muscarinic acetylcholine receptors confers selective and long-lasting desensitization of signaling to phospholipase C.
J Neurochem
74:1721-1730[Web of Science][Medline].
-
Lapierre LA,
Kumar R,
Hales CM,
Navarre J,
Bhartur SG,
Burnette JO,
Provance Jr DW,
Mercer JA,
Bahler M,
Goldenring JR
(2001)
Myosin vb is associated with plasma membrane recycling systems.
Mol Biol Cell
12:1843-1857[Abstract/Free Full Text].
-
Lefkowitz RJ
(1998)
G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization.
J Biol Chem
273:18677-18680[Free Full Text].
-
Levey AI,
Kitt CA,
Simonds WF,
Price DL,
Brann MR
(1991)
Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies.
J Neurosci
11:3218-3226[Abstract].
-
Mellman I
(1996)
Endocytosis and molecular sorting.
Annu Rev Cell Dev Biol
12:575-625[Web of Science][Medline].
-
Moore RH,
Tuffaha A,
Millman EE,
Dai W,
Hall HS,
Dickey BF,
Knoll BJ
(1999)
Agonist-induced sorting of human beta2-adrenergic receptors to lysosomes during downregulation.
J Cell Sci
112:329-338[Abstract].
-
Muriel MP,
Bernard V,
Levey AI,
Laribi O,
Abrous DN,
Agid Y,
Bloch B,
Hirsch EC
(1999)
Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease.
Ann Neurol
46:103-111[Web of Science][Medline].
-
Prekeris R,
Klumperman J,
Scheller RH
(2000)
A Rab11/Rip11 protein complex regulates apical membrane trafficking via recycling endosomes.
Mol Cell
6:1437-1448[Web of Science][Medline].
-
Prekeris R,
Davies JM,
Scheller RH
(2001)
Identification of a novel Rab11/25 binding domain present in Eferin and Rip proteins.
J Biol Chem
276:38966-38970[Abstract/Free Full Text].
-
Ren M,
Xu G,
Zeng J,
De Lemos-Chiarandini C,
Adesnik M,
Sabatini DD
(1998)
Hydrolysis of GTP on rab11 is required for the direct delivery of transferrin from the pericentriolar recycling compartment to the cell surface but not from sorting endosomes.
Proc Natl Acad Sci USA
95:6187-6192[Abstract/Free Full Text].
-
Roche KW,
Standley S,
McCallum J,
Dune Ly C,
Ehlers MD,
Wenthold RJ
(2001)
Molecular determinants of NMDA receptor internalization.
Nat Neurosci
4:794-802[Web of Science][Medline].
-
Rubino M,
Miaczynska M,
Lippe R,
Zerial M
(2000)
Selective membrane recruitment of EEA1 suggests a role in directional transport of clathrin-coated vesicles to early endosomes.
J Biol Chem
275:3745-3748[Abstract/Free Full Text].
-
Seachrist JL,
Anborgh PH,
Ferguson SS
(2000)
beta 2-adrenergic receptor internalization, endosomal sorting, and plasma membrane recycling are regulated by rab GTPases.
J Biol Chem
275:27221-27228[Abstract/Free Full Text].
-
Sheehan D,
Ray GS,
Calhoun BC,
Goldenring JR
(1996)
A somatodendritic distribution of Rab11 in rabbit brain neurons.
NeuroReport
7:1297-1300[Web of Science][Medline].
-
Sonnichsen B,
De Renzis S,
Nielsen E,
Rietdorf J,
Zerial M
(2000)
Distinct membrane domains on endosomes in the recycling pathway visualized by multicolor imaging of Rab4, Rab5, and Rab11.
J Cell Biol
149:901-914[Abstract/Free Full Text].
-
St. John PA,
Gordon H
(2001)
Agonists cause endocytosis of nicotinic acetylcholine receptors on cultured myotubes.
J Neurobiol
49:212-223[Web of Science][Medline].
-
Szekeres PG,
Koenig JA,
Edwardson JM
(1998)
Involvement of receptor cycling and receptor reserve in resensitization of muscarinic responses in SH-SY5Y human neuroblastoma cells.
J Neurochem
70:1694-1703[Web of Science][Medline].
-
Tolbert LM,
Lameh J
(1996)
Human muscarinic cholinergic receptor Hm1 internalizes via clathrin-coated vesicles.
J Biol Chem
271:17335-17342[Abstract/Free Full Text].
-
Trejo J,
Coughlin SR
(1999)
The cytoplasmic tails of protease-activated receptor-1 and substance P receptor specify sorting to lysosomes versus recycling.
J Biol Chem
274:2216-2224[Abstract/Free Full Text].
-
Tsao PI,
von Zastrow M
(2000)
Type-specific sorting of G protein-coupled receptors after endocytosis.
J Biol Chem
275:11130-11140[Abstract/Free Full Text].
-
Ullrich O,
Horiuchi H,
Bucci C,
Zerial M
(1994)
Membrane association of Rab5 mediated by GDP-dissociation inhibitor and accompanied by GDP/GTP exchange.
Nature
368:157-160[Medline].
-
Ullrich O,
Reinsch S,
Urbe S,
Zerial M,
Parton RG
(1996)
Rab11 regulates recycling through the pericentriolar recycling endosome.
J Cell Biol
135:913-924[Abstract/Free Full Text].
-
van der Sluijs P,
Hull M,
Webster P,
Male P,
Goud B,
Mellman I
(1992)
The small GTP-binding protein rab4 controls an early sorting event on the endocytic pathway.
Cell
70:729-740[Web of Science][Medline].
-
Volpicelli LA,
Lah JJ,
Levey AI
(2001)
Rab5-dependent trafficking of the m4 muscarinic acetylcholine receptor to the plasma membrane, early endosomes, and multivesicular bodies.
J Biol Chem
276:47590-47598[Abstract/Free Full Text].
-
von Zastrow M,
Kobilka BK
(1992)
Ligand-regulated internalization and recycling of human beta 2-adrenergic receptors between the plasma membrane and endosomes containing transferrin receptors.
J Biol Chem
267:3530-3538[Abstract/Free Full Text].
-
Wang H,
Han H,
Zhang L,
Shi H,
Schram G,
Nattel S,
Wang Z
(2001)
Expression of multiple subtypes of muscarinic receptors and cellular distribution in the human heart.
Mol Pharmacol
59:1029-1036[Abstract/Free Full Text].
-
Whistler JL,
Chuang HH,
Chu P,
Jan LY,
von Zastrow M
(1999)
Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction.
Neuron
23:737-746[Web of Science][Medline].
-
Yamashiro DJ,
Tycko B,
Fluss SR,
Maxfield FR
(1984)
Segregation of transferrin to a mildly acidic (pH 6.5) para-Golgi compartment in the recycling pathway.
Cell
37:789-800[Web of Science][Medline].
-
Zhang W,
Basile AS,
Gomeza J,
Volpicelli LA,
Levey AI,
Wess J
(2002)
Characterization of central inhibitory muscarinic autoreceptors by the use of muscarinic acetylcholine receptor knock-out mice.
J Neurosci
22:1709-1717[Abstract/Free Full Text].
-
Zhao LP,
Koslovsky JS,
Reinhard J,
Bahler M,
Witt AE,
Provance Jr DW,
Mercer JA
(1996)
Cloning and characterization of myr 6, an unconventional myosin of the dilute/myosin-V family.
Proc Natl Acad Sci USA
93:10826-10831[Abstract/Free Full Text].
Copyright © 2002 Society for Neuroscience 0270-6474/02/22229776-09$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
M.-F. Lise, D. P. Srivastava, P. Arstikaitis, R. L. Lett, R. Sheta, V. Viswanathan, P. Penzes, T. P. O'Connor, and A. El-Husseini
Myosin-Va-interacting protein, RILPL2, controls cell shape and neuronal morphogenesis via Rac signaling
J. Cell Sci.,
October 15, 2009;
122(20):
3810 - 3821.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. W. Jones and P. M. Hinkle
Subcellular Trafficking of the TRH Receptor: Effect of Phosphorylation
Mol. Endocrinol.,
September 1, 2009;
23(9):
1466 - 1478.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B.-B. Chu, L. Ge, C. Xie, Y. Zhao, H.-H. Miao, J. Wang, B.-L. Li, and B.-L. Song
Requirement of Myosin Vb{middle dot}Rab11a{middle dot}Rab11-FIP2 Complex in Cholesterol-regulated Translocation of NPC1L1 to the Cell Surface
J. Biol. Chem.,
August 14, 2009;
284(33):
22481 - 22490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. Roland, L. A. Lapierre, and J. R. Goldenring
Alternative Splicing in Class V Myosins Determines Association with Rab10
J. Biol. Chem.,
January 9, 2009;
284(2):
1213 - 1223.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Garcia-Regalado, M. L. Guzman-Hernandez, I. Ramirez-Rangel, E. Robles-Molina, T. Balla, J. Vazquez-Prado, and G. Reyes-Cruz
G Protein-coupled Receptor-promoted Trafficking of G{beta}1{gamma}2 Leads to AKT Activation at Endosomes via a Mechanism Mediated by G{beta}1{gamma}2-Rab11a Interaction
Mol. Biol. Cell,
October 1, 2008;
19(10):
4188 - 4200.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wan, A. Y. Cheung, W.-Y. Fu, C. Wu, M. Zhang, W. C. Mobley, Z. H. Cheung, and N. Y. Ip
Endophilin B1 as a Novel Regulator of Nerve Growth Factor/ TrkA Trafficking and Neurite Outgrowth
J. Neurosci.,
September 3, 2008;
28(36):
9002 - 9012.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Giles, J. Chen, L. Li, and L.-S. Chin
Dystonia-associated mutations cause premature degradation of torsinA protein and cell-type-specific mislocalization to the nuclear envelope
Hum. Mol. Genet.,
September 1, 2008;
17(17):
2712 - 2722.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Wang, X. Chen, X. Zhang, and L. Ma
Phosphorylation State of {micro}-Opioid Receptor Determines the Alternative Recycling of Receptor via Rab4 or Rab11 Pathway
Mol. Endocrinol.,
August 1, 2008;
22(8):
1881 - 1892.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Bonecchi, E. M. Borroni, A. Anselmo, A. Doni, B. Savino, M. Mirolo, M. Fabbri, V. R. Jala, B. Haribabu, A. Mantovani, et al.
Regulation of D6 chemokine scavenging activity by ligand- and Rab11-dependent surface up-regulation
Blood,
August 1, 2008;
112(3):
493 - 503.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Polavarapu, J. An, C. Zhang, and M. Yepes
Regulated Intramembrane Proteolysis of the Low-Density Lipoprotein Receptor-Related Protein Mediates Ischemic Cell Death
Am. J. Pathol.,
May 1, 2008;
172(5):
1355 - 1362.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Watanabe, T. M. Watanabe, O. Sato, J. Awata, K. Homma, N. Umeki, H. Higuchi, R. Ikebe, and M. Ikebe
Human Myosin Vc Is a Low Duty Ratio Nonprocessive Motor
J. Biol. Chem.,
April 18, 2008;
283(16):
10581 - 10592.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Takagi, Y. Yang, I. Fujiwara, D. Jacobs, R. E. Cheney, J. R. Sellers, and M. Kovacs
Human Myosin Vc Is a Low Duty Ratio, Nonprocessive Molecular Motor
J. Biol. Chem.,
March 28, 2008;
283(13):
8527 - 8537.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. A. Ducharme, J. A. Williams, A. Oztan, G. Apodaca, L. A. Lapierre, and J. R. Goldenring
Rab11-FIP2 regulates differentiable steps in transcytosis
Am J Physiol Cell Physiol,
September 1, 2007;
293(3):
C1059 - C1072.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Swiatecka-Urban, L. Talebian, E. Kanno, S. Moreau-Marquis, B. Coutermarsh, K. Hansen, K. H. Karlson, R. Barnaby, R. E. Cheney, G. M. Langford, et al.
Myosin Vb Is Required for Trafficking of the Cystic Fibrosis Transmembrane Conductance Regulator in Rab11a-specific Apical Recycling Endosomes in Polarized Human Airway Epithelial Cells
J. Biol. Chem.,
August 10, 2007;
282(32):
23725 - 23736.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. Roland, A. K. Kenworthy, J. Peranen, S. Caplan, and J. R. Goldenring
Myosin Vb Interacts with Rab8a on a Tubular Network Containing EHD1 and EHD3
Mol. Biol. Cell,
August 1, 2007;
18(8):
2828 - 2837.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. X. Li, A. K. Satoh, and D. F. Ready
Myosin V, Rab11, and dRip11 direct apical secretion and cellular morphogenesis in developing Drosophila photoreceptors
J. Cell Biol.,
May 21, 2007;
177(4):
659 - 669.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Lapierre, K. M. Avant, C. M. Caldwell, A.-J. L. Ham, S. Hill, J. A. Williams, A. J. Smolka, and J. R. Goldenring
Characterization of immunoisolated human gastric parietal cells tubulovesicles: identification of regulators of apical recycling
Am J Physiol Gastrointest Liver Physiol,
May 1, 2007;
292(5):
G1249 - G1262.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. L. Prigozhina and C. M. Waterman-Storer
Decreased polarity and increased random motility in PtK1 epithelial cells correlate with inhibition of endosomal recycling.
J. Cell Sci.,
September 1, 2006;
119(Pt 17):
3571 - 3582.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. A. Ducharme, C. M. Hales, L. A. Lapierre, A.-J. L. Ham, A. Oztan, G. Apodaca, and J. R. Goldenring
MARK2/EMK1/Par-1B{alpha} Phosphorylation of Rab11-Family Interacting Protein 2 Is Necessary for the Timely Establishment of Polarity in Madin-Darby Canine Kidney Cells
Mol. Biol. Cell,
August 1, 2006;
17(8):
3625 - 3637.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Helms, A. Ambit, P. Appleton, L. Tetley, G. H. Coombs, and J. C. Mottram
Bloodstream form Trypanosoma brucei depend upon multiple metacaspases associated with RAB11-positive endosomes
J. Cell Sci.,
March 15, 2006;
119(6):
1105 - 1117.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-F. Lise, T. P. Wong, A. Trinh, R. M. Hines, L. Liu, R. Kang, D. J. Hines, J. Lu, J. R. Goldenring, Y. T. Wang, et al.
Involvement of Myosin Vb in Glutamate Receptor Trafficking
J. Biol. Chem.,
February 10, 2006;
281(6):
3669 - 3678.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Swiatecka-Urban, A. Brown, S. Moreau-Marquis, J. Renuka, B. Coutermarsh, R. Barnaby, K. H. Karlson, T. R. Flotte, M. Fukuda, G. M. Langford, et al.
The Short Apical Membrane Half-life of Rescued {Delta}F508-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Results from Accelerated Endocytosis of {Delta}F508-CFTR in Polarized Human Airway Epithelial Cells
J. Biol. Chem.,
November 4, 2005;
280(44):
36762 - 36772.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. Song and P. M. Hinkle
Regulated Dimerization of the Thyrotropin-Releasing Hormone Receptor Affects Receptor Trafficking But Not Signaling
Mol. Endocrinol.,
November 1, 2005;
19(11):
2859 - 2870.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Hamelin, C. Theriault, G. Laroche, and J.-L. Parent
The Intracellular Trafficking of the G Protein-coupled Receptor TP{beta} Depends on a Direct Interaction with Rab11
J. Biol. Chem.,
October 28, 2005;
280(43):
36195 - 36205.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wakabayashi, P. Dutt, J. Lippincott-Schwartz, and I. M. Arias
Rab11a and myosin Vb are required for bile canalicular formation in WIF-B9 cells
PNAS,
October 18, 2005;
102(42):
15087 - 15092.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Krendel and M. S. Mooseker
Myosins: Tails (and Heads) of Functional Diversity
Physiology,
August 1, 2005;
20(4):
239 - 251.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. S. Hall, E. Smith, W. Langer, L. A. Jacobs, D. Goulding, and M. C. Field
Developmental Variation in Rab11-Dependent Trafficking in Trypanosoma brucei
Eukaryot. Cell,
May 1, 2005;
4(5):
971 - 980.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Yan, W. Sun, P. Kujala, Y. Lotfi, T. A. Vida, and A. J. Bean
CART: An Hrs/Actinin-4/BERP/Myosin V Protein Complex Required for Efficient Receptor Recycling
Mol. Biol. Cell,
May 1, 2005;
16(5):
2470 - 2482.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Z. Gerges, D. S. Backos, and J. A. Esteban
Local Control of AMPA Receptor Trafficking at the Postsynaptic Terminal by a Small GTPase of the Rab Family
J. Biol. Chem.,
October 15, 2004;
279(42):
43870 - 43878.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Weigert, A. C. Yeung, J. Li, and J. G. Donaldson
Rab22a Regulates the Recycling of Membrane Proteins Internalized Independently of Clathrin
Mol. Biol. Cell,
August 1, 2004;
15(8):
3758 - 3770.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. H. Moore, E. E. Millman, E. Alpizar-Foster, W. Dai, and B. J. Knoll
Rab11 regulates the recycling and lysosome targeting of {beta}2-adrenergic receptors
J. Cell Sci.,
July 1, 2004;
117(15):
3107 - 3117.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G.-H. Fan, L. A. Lapierre, J. R. Goldenring, J. Sai, and A. Richmond
Rab11-Family Interacting Protein 2 and Myosin Vb Are Required for CXCR2 Recycling and Receptor-mediated Chemotaxis
Mol. Biol. Cell,
May 1, 2004;
15(5):
2456 - 2469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. B. Dale, J. L. Seachrist, A. V. Babwah, and S. S. G. Ferguson
Regulation of Angiotensin II Type 1A Receptor Intracellular Retention, Degradation, and Recycling by Rab5, Rab7, and Rab11 GTPases
J. Biol. Chem.,
March 26, 2004;
279(13):
13110 - 13118.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. W. Provance Jr., C. R. Gourley, C. M. Silan, L. C. Cameron, K. M. Shokat, J. R. Goldenring, K. Shah, P. G. Gillespie, and J. A. Mercer
From the Cover: Chemical-genetic inhibition of a sensitized mutant myosin Vb demonstrates a role in peripheral-pericentriolar membrane traffic
PNAS,
February 17, 2004;
101(7):
1868 - 1873.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Loder and H. E. Melikian
The Dopamine Transporter Constitutively Internalizes and Recycles in a Protein Kinase C-regulated Manner in Stably Transfected PC12 Cell Lines
J. Biol. Chem.,
June 6, 2003;
278(24):
22168 - 22174.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|